Tag Archives: Therapeutic Drug Monitoring Market

Therapeutic Drug Monitoring Market Major Competitor and Strategies, Regional Outlook to 2024

16th December 2019 – The ****** therapeutic drug monitoring market size is expected to value at USD 3.37 billion by 2024. The market is subject to witness a substantial growth due to the introduction of the Point-of-Care (PoC) devices in the market and development of the personalized predictive and preventive medicine. Factors responsible for the robust growth of therapeutic drug monitoring (TDM) market, in the recent years, include deriving personalized or tailor-made treatment plans for patients and increasing adoption of the Point-of-Care (PoC) diagnostic devices to carry out quantitative measurements of the drug concentration. Advent of the precision medicine for the healthcare sectoris expected to drive the growth of the market.

Therapeutic Drug Monitoring Market Size, Share, Outlook, Industry Analysis Report 2019

Major players in the Therapeutic Drug Monitoring Market were identified through secondary research and their market presence was studied through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, white papers, medical journals, certified publications, articles from recognized authors, directories, databases such as WHO, OECD, American Association for Clinical Chemistry (AACC), European Federation of Pharmaceutical Industries and Associations (EFPIA), International Trade Association, NCBI, and National Health Service (NHS).

Therapeutic Drug Monitoring Market Analysis by Key players, Applications and Forecast

According to the new market research report Therapeutic Drug Monitoring Market by Product (Consumable, Equipment (Immunoassay analyzer)), Technology (Fluorescence Immunoassay, Radioimmunoassay, GCMS), Class of drugs (Antibiotics, Bronchodilators), End-User (Hospital Lab) – ****** Forecast to 2023″, published by MarketsandMarkets™, the ****** therapeutic drug monitoring market is projected to reach USD 1.63 billion in 2023 from USD 1.23 billion in 2018, at a CAGR of 5.9%

The growth of this market is majorly driven by the rising number of organ transplant procedures and the use of TDM in traditional anticancer therapies.

Download PDF Brochure:

Therapeutic Drug Monitoring Market: ****** Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

****** Therapeutic Drug Monitoring Market: By Product (Equipment (Proteomics Equipment, Immuno Assay Analysers and Others) and Consumables), By Drug class (Antibiotics, Immunosuppressant’s, Anti-Epileptic Drugs, Psychoactive Drugs, Anti-Arrhythmic Drugs and Others), By end user (Hospitals, Clinical Laboratories and Others) By Geography – Therapeutic Drug Monitoring Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023


Market Outline: ****** Therapeutic Drug Monitoring Market